Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Dexcom Announces Release of Clarity Mobile App

Dexcom
Posted on: 11 Oct 18
Dexcom Announces Release of Clarity Mobile App

PR Newswire

EDINBURGH, October 11, 2018

EDINBURGH, October 11, 2018 /PRNewswire/ --

Mobile app allows patients to quickly access glucose data on their phone for diabetes management 

Dexcom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today the release of the CLARITY mobile app.

     (Logo: http://mma.prnewswire.com/media/553571/Dexcom_Logo.jpg )

The Dexcom CLARITY® Diabetes Management Software is a cloud-based solution that simplifies CGM data reporting and facilitates the secure sharing of data between physicians and their patients. Now, with the CLARITY app, patients can view glucose insights with just a quick glance at their phone.

Key features on the app include:

  • Push notifications and summary emails delivering weekly insights directly to patients
  • Summary dashboard to view glucose metrics for selected time-period (7, 14, 30 and 90 days), including: time in range, estimated HbA1c (eHbA1c), average glucose and hypoglycaemia risk
  • Generate reports to save, print or email
  • Authorise data sharing between patient and clinic to make appointments more efficient

First launched for desktop, the Dexcom CLARITY diabetes management solution enables patients and clinics to review past glucose levels from the Dexcom CGM over user-defined time periods. Dexcom CLARITY offers a range of reports to meet varying user needs. Dexcom CLARITY's Overview report provides high-level metrics like estimated HbA1c and average glucose. CLARITY also compiles glucose trend data to identify patterns of hypoglycaemia (low blood sugar) and hyperglycaemia (high blood sugar). Dexcom CLARITY also has an Ambulatory Glucose Profile (AGP), a licensed, standardised glucose report created by the International Diabetes Center (IDC), that provides a big picture view of diabetes management.

The CLARITY app is compatible with iPhone, iPad, and iPod touch (requires iOS 10.3 or later) and any Android Device using OS version 6.0 or later. Please see here for full compatibility: https://www.dexcom.com/dexcom-international-compatibility.

The CLARITY app is now available in the following countries: Austria, Denmark, Finland, Germany, Hong Kong, Ireland, Luxembourg, Lebanon, Netherlands, Norway, Oman, Qatar, Sweden, Switzerland and the United Kingdom.

To review features and download from your app store, please visit here: https://clarity.dexcom.eu/mobile

About Dexc om, Inc. 
Founded in 1999, Dexcom, Inc. has corporate offices in San Diego, California, EMEA headquarters in Edinburgh, Scotland and users in 39 countries around the world. At Dexcom, we are transforming diabetes care and management by providing superior continuous glucose monitoring (CGM) technology to help people with diabetes and healthcare professionals better manage diabetes. Since our inception, we have focused on better outcomes for people with diabetes, caregivers, and clinicians by delivering solutions that are best in class-while empowering our community to take control of diabetes. For more information on Dexcom CGM, visit http://www.dexcom.com/global.

PR Newswire
www.prnewswire.com

Last updated on: 11/10/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.